UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
NEW YORK, Feb. 23, 2018 -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. (“Ekso Bionics” or the “Company”) (NASDAQ:EKSO).
On December 14, 2017, Ekso Bionics advised investors that “the Company’s internal control over financial reporting as of December 31, 2016 should no longer be relied upon and that a material weakness in the Company's internal control over financial reporting existed as of such date.” Then on December 27, 2017, the Company filed an amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017.
On this news, Ekso Bionics’ share price declined.
If you invested in Ekso Bionics stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/EKSO. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
